Market Research Logo

Global Stem Cell Therapy Market 2017-2021

About stem cell therapy

Stem cell therapy is the use of stem cells for the treatment or prevention of a disease or condition. Bone marrow transplant is the widely-used stem cell therapy, followed by therapies derived from umbilical cord blood. Research is being undertaken to develop various sources (such as cord blood cells, bone marrow, and skin) for stem cells, and to apply them to various disorders like neurodegenerative diseases and conditions such as heart disease, diabetes, and other conditions.

Technavio’s analysts forecast the global stem cell therapy market to grow at a CAGR of 36.52% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global stem cell therapy market for 2017-2021. To calculate the market size, the report considers the sales of stem cell therapy products/segments in the market.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Stem Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Holostem Advanced Therapies
  • JCR Pharmaceuticals
  • Organogenesis
  • Osiris Therapeutics
  • Vericel
Other prominent vendors
  • AbbVie
  • American CryoStem
  • AM-Pharma
  • Anterogen
  • apceth Biopharma
  • Astellas Pharma
  • Athersys
  • Baxter International
  • Beike Biotechnology
  • BIOTIME
  • bluebird bio
  • Bristol-Myers Squibb
  • BrainStorm Cell Therapeutics
  • Brainxell
  • Caladrius Biosciences
  • Cellular Biomedicine Group
  • Cellular Dynamics International (a subsidiary of Fujifilm)
  • Cesca Therapeutics
  • CHA Biotech
  • Chugai Pharmaceutical
  • Citospin
  • Corestem
  • Cytori Therapeutics
  • Daiichi Sankyo
  • Fujifilm
  • Gamida Cell
  • Global Stem Cells Group
  • Grupo Ferrer Internacional
  • GlaxoSmithKline
  • Hemostemix
  • Histocell
  • International Stem Cell
  • Ivy Institute of Stem Cells
  • Japan Regenerative Medicine
  • Kangstem Biotech
  • Kiadis Pharma
  • Laboratorios Salvat
  • MEDIPOST
  • Mesoblast
  • Nuo Therapeutics
  • Opsis Therapeutics
  • Osiris Therapeutics
  • Pharmicell
  • Pluristem Therapeutics
  • Promethera Biosciences
  • Q Therapeutics
  • ReNeuron
  • RHEACELL
  • Salus Medical Solutions
  • Sangamo Therapeutics
  • Shire
  • Steminent Biotherapeutics
  • Sumitomo Dainippon Pharma
  • Taiwan Bio Therapeutics
  • Takeda Pharmaceutical
  • Teva Pharmaceutical Industries
  • Thoratec Corporation
  • TiGenix
  • Translational Biosciences
  • TWO CELLS
  • U.S. Stem Cell
  • ViaCyte
  • VistaGen Therapeutics
Market driver
  • Increase in federal funding in stem cell therapy
  • For a full, detailed list, view our report
Market challenge
  • Stringent regulatory environment affecting the product approvals
  • For a full, detailed list, view our report
Market trend
  • Evolution of new destinations in the development of stem cell therapies
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Stem Cell Therapy Market 2017-2021

Technavio recognizes the following companies as the key players in the global stem cell therapy market: Holostem Advanced Therapies, JCR Pharmaceuticals, Organogenesis, Osiris Therapeutics, and Vericel.

Other Prominent Vendors in the market are: AbbVie, American CryoStem, AM-Pharma, Anterogen, apceth Biopharma, Astellas Pharma, Athersys, Baxter International, Beike Biotechnology, BIOTIME, bluebird bio, Bristol-Myers Squibb, BrainStorm Cell Therapeutics, Brainxell, Caladrius Biosciences, Cellular Biomedicine Group, Cellular Dynamics International (a subsidiary of Fujifilm), Cesca Therapeutics, CHA Biotech, Chugai Pharmaceutical, Citospin, Corestem, Cytori Therapeutics, Daiichi Sankyo, Fujifilm, Gamida Cell, Global Stem Cells Group, Grupo Ferrer Internacional, GlaxoSmithKline, Hemostemix, Histocell, International Stem Cell, Ivy Institute of Stem Cells, Japan Regenerative Medicine, Kangstem Biotech, Kiadis Pharma, Laboratorios Salvat, MEDIPOST, Mesoblast, Nuo Therapeutics, Opsis Therapeutics, Osiris Therapeutics, Pharmicell, Pluristem Therapeutics, Promethera Biosciences, Q Therapeutics, ReNeuron, RHEACELL, Salus Medical Solutions, Sangamo Therapeutics, Shire, Steminent Biotherapeutics, Sumitomo Dainippon Pharma, Taiwan Bio Therapeutics, Takeda Pharmaceutical, Teva Pharmaceutical Industries, Thoratec Corporation, TiGenix, Translational Biosciences, TWO CELLS, U.S. Stem Cell, ViaCyte, and VistaGen Therapeutics.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is evolution of new destinations in the development of stem cell therapies. Traditionally, the US and European countries are the key destinations for clinical trials for stem cell therapy products. However, the transformation of regulatory landscape in countries such as Japan and South Korea has made these regions as attractive destinations for the development of stem cell therapy products.”

According to the report, one of the major drivers for this market is increase in federal funding in stem cell therapy. Research and clinical trials of stem cell therapy require huge investment, which many research institutes and small companies cannot afford. Therefore, many federal organizations provide funding to these institutes and small companies to help their innovative ideas in the development of stem cell therapies. Worldwide, many government organizations have noticed the importance of regenerative medicine, and thus they have allocated funds and grants in that area. For instance, in the US, the NIH and CIRM provide most of the funds.

Further, the report states that one of the major factors hindering the growth of this market is stringent regulatory environment affecting the product approvals. Gaining regulatory approval is often difficult, unpredictable, and subjective. Stem cell therapy must undergo a broad range of stringent regulations before approval and commercialization. Currently, the US FDA has approved very few products for stem cell therapy. However, many individuals visit doctors for transplantation of cell therapy or stem cell implants that are not approved by regulatory bodies.

Companies Mentioned

Holostem Advanced Therapies, JCR Pharmaceuticals, Organogenesis, Osiris Therapeutics, Vericel, AbbVie, American CryoStem, AM-Pharma, Anterogen, apceth Biopharma, Astellas Pharma, Athersys, Baxter International, Beike Biotechnology, BIOTIME, bluebird bio, Bristol-Myers Squibb, BrainStorm Cell Therapeutics, Brainxell, Caladrius Biosciences, Cellular Biomedicine Group, Cellular Dynamics International (a subsidiary of Fujifilm), Cesca Therapeutics, CHA Biotech, Chugai Pharmaceutical, Citospin, Corestem, Cytori Therapeutics, Daiichi Sankyo, Fujifilm, Gamida Cell, Global Stem Cells Group, Grupo Ferrer Internacional, GlaxoSmithKline, Hemostemix, Histocell, International Stem Cell, Ivy Institute of Stem Cells, Japan Regenerative Medicine, Kangstem Biotech, Kiadis Pharma, Laboratorios Salvat, MEDIPOST, Mesoblast, Nuo Therapeutics, Opsis Therapeutics, Osiris Therapeutics, Pharmicell, Pluristem Therapeutics, Promethera Biosciences, Q Therapeutics, ReNeuron, RHEACELL, Salus Medical Solutions, Sangamo Therapeutics, Shire, Steminent Biotherapeutics, Sumitomo Dainippon Pharma, Taiwan Bio Therapeutics, Takeda Pharmaceutical, Teva Pharmaceutical Industries, Thoratec Corporation, TiGenix, Translational Biosciences, TWO CELLS, U.S. Stem Cell, ViaCyte, VistaGen Therapeutics.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Key market highlights
  • Understanding of stem cell therapy
    • History of stem cell research
      • Table Developments in stem cell research
  • Ethical issues and regulatory landscape
    • Ethical issues of stem cell research at different phases of research
      • Table Ethical issues faced by various institutes at different phases of cell therapy research
      • Table Stem cell research policies in Americas
      • Table Stem cell research policies in EMEA
      • Table Stem cell research policies in APAC
  • Key clinical trials
    • Table Historical trend of pipeline candidates in different phases
    • Table Snapshot of pipeline trends in stem cell therapy market
    • Table Pipeline landscape by therapeutic area 2016
    • Table Pipeline by development phase 2016
    • Table Pipeline snapshot in key therapy areas
    • Table Brief overview of attractive clinical trial locations, therapy areas, and cell types
    • Attractive clinical trial locations to invest
    • Commercially attractive therapy areas to invest
      • Table Key clinical trials
  • Market landscape
    • Market overview
      • Table Global stem cell therapy market snapshot
      • Table Key marketed products and their company
      • Table Key vendors with robust Phase III pipeline
      • Table Global stem cell therapy market 2016-2021 ($ millions)
      • Table Opportunity analysis in global stem cell therapy market
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by therapy
    • Table Global stem cell therapy market segmentation by therapy 2016
    • Allogeneic stem cell therapy
      • Table Global allogeneic stem cell therapy market 2016-2021 ($ millions)
      • Table Opportunity analysis of allogeneic stem cell therapy market
    • Autologous stem cell therapy
      • Table Global autologous stem cell therapy market 2016-2021 ($ millions)
      • Table Opportunity analysis of autologous stem cell therapy market
  • Market segmentation by applications
    • Table Global stem cell therapy market segmentation by application 2016
    • Dermatology
      • Table Overview of dermatology in stem cell therapy market
    • Musculoskeletal
      • Table Overview of musculoskeletal in regenerative medicine market
    • Cardiovascular
      • Table Overview of cardiovascular in stem cell therapy market
  • Geographical segmentation
    • Table Segmentation of global stem cell therapy market based on geography 2016 and 2021
    • Table Stem cell therapy market revenue by geography 2016-2021 ($ millions)
    • Stem cell therapy market in Americas
      • Table Market scenario in Americas
      • Table Stem cell therapy market in Americas ($ millions)
    • Stem cell therapy market in EMEA
      • Table Market scenario in EMEA
      • Table Stem cell therapy market in EMEA ($ millions)
    • Stem cell therapy market in APAC
      • Table Market scenario in APAC
      • Table Stem cell therapy market in APAC ($ millions)
      • Table Key stem cell therapy market developments in Japan by global vendors 2015
  • Market drivers
    • Limitations in traditional organ transplantations fueling the demand for stem cell therapies
    • Increase in federal funding in stem cell therapy
      • Table NIH: YoY and growth rate of spending toward stem cell research ($ billions)
      • Table Breakdown of CIRM funding in various stem cell research funding in 2014 ($ billions)
      • Table Active programs under CIRM 2014
      • Table Details of EC funding
    • Growing demand for personalized medicine
    • Increasing demand to develop effective drugs for cardiology and degenerative disorders
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Stringent regulatory environment affecting the product approvals
    • Critical ethical challenges with respect to stem cell research
    • High cost of clinical trials and failure rate in clinical trials
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Evolution of new destinations in the development of stem cell therapies
      • Table Regulatory guidelines in Japan
    • Increasing inorganic growth strategies such as acquisitions and licensing agreements
      • Table Key inorganic growth strategies in global stem cell therapy market
    • Growing focus on the development of drugs for emerging applications
    • Increasing investments from private enterprises likely to fuel market growth
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global stem cell therapy market 2016
      • Table Competitive analysis of global stem cell therapy market
      • Table Some of the key approvals in global stem cell therapy
      • Table Strategic success factors of companies in global stem cell therapy market
  • Key vendor analysis
    • Holostem Advanced Therapies
      • Table Holostem Advanced Therapies: Key highlights
      • Table Holostem Advanced Therapies: Strength assessment
      • Table Holostem Advanced Therapies: Strategy assessment
      • Table Holostem Advanced Therapies: Opportunity assessment
    • JCR Pharmaceuticals
      • Table JCR Pharmaceuticals: Strength assessment
      • Table JCR Pharmaceuticals: Strategy assessment
      • Table JCR Pharmaceuticals: Opportunity assessment
    • Organogenesis
      • Table Organogenesis: Key highlights
      • Table Organogenesis: Strength assessment
      • Table Organogenesis: Strategy assessment
      • Table Organogenesis: Opportunity assessment
    • Osiris Therapeutics
      • Table Osiris Therapeutics: Key highlights
      • Table Osiris Therapeutics: Strength assessment
      • Table Osiris Therapeutics: Strategy assessment
      • Table Osiris Therapeutics: Opportunity assessment
    • Vericel
      • Table Vericel: Key highlights
      • Table Vericel: Strength assessment
      • Table Vericel: Strategy assessment
      • Table Vericel: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report